aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
viernes, 2 de agosto de 2024
Advancing Generic Drug Development: Translating Science to Approval 2024 September 24 - 25, 2024
https://www.fda.gov/drugs/news-events-human-drugs/advancing-generic-drug-development-translating-science-approval-2024-09242024?utm_medium=email&utm_source=govdelivery
Join us for the 2024 Advancing Generic Drug Development workshop. FDA experts will discuss and analyze the complex scientific issues encountered in generic drug development and abbreviated new drug applications (ANDAs). This workshop promises to be an invaluable opportunity to:
Gain insights into GDUFA III updates and the latest scientific research on complex products
Explore product-specific guidance development, pre-ANDA, and ANDA meeting discussions
Discover innovative science and cutting-edge methodologies driving generic drug development
We hope you can join us in person! In-person attendees will engage with FDA scientists during a poster session, featuring topics such as:
Research supporting guidance development
Advanced analytical methods
PBPK modeling
Post-market surveillance
ANDA assessment
And more!
No hay comentarios:
Publicar un comentario